Name: MMB-CHMICA, AMB-CHMICA (methyl 2-(1-(cyclohexylmethyl)-1 H-indole-3-carboxamido)-3-methylbutanoate)
Type: Synthetic cannabinoid
AKA: N/A
|
II. Natural Derivative
Synthetic substance, no natural derivative
|
III. Chemical Profile (IUPAC name)
|
IV. History
MMB-CHMINACA and AMB-CHMINACA are synthetic cannabinoids developed in the 2010s. They are part of research into synthetic cannabinoids, designed to mimic THC's effects. Their recreational use has raised concerns, leading to their regulation due to safety and abuse potential.
|
V. Legal Information
MMB-CHMINACA and AMB-CHMINACA, synthetic cannabinoids, are often regulated under analog laws due to their psychoactive effects. Their status varies by jurisdiction, reflecting efforts to manage novel psychoactive substances.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
VI. Physical Effects
MMB-CHMICA and AMB-CHMICA are synthetic cannabinoids with potent psychoactive effects. They increase heart rate and blood pressure, acting as uppers. Short-term use may lead to intense psychoactive effects, while long-term use poses risks of cardiovascular issues and psychological problems. Overdose risks include severe agitation, hallucinations, and cardiovascular effects. Safe use involves cautious dosing and monitoring. Recent research focuses on their psychoactive effects and associated health risks. |
VII. Psychological Effects
MMB-CHMINACA and AMB-CHMINACA, synthetic cannabinoids, affect cannabinoid receptors, leading to altered mood and perception. Immediate effects include euphoria and relaxation, while long-term use may cause cognitive impairments and psychological issues. Research examines their potency and psychological impact.
|
VIII. Culture
MMB-CHMINACA and AMB-CHMINACA are synthetic cannabinoids with no historical lore, emerging in the 21st century. Their cultural impact is related to their use as legal highs and associated health risks. Proponents highlight their effects, while opponents caution about health dangers and regulatory challenges. Their use is primarily recreational, reflecting broader issues in synthetic drug use and regulation.
|